74 related articles for article (PubMed ID: 22665137)
1. Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice.
Porter WD; Flatt PR; Hölscher C; Gault VA
Int J Obes (Lond); 2013 May; 37(5):678-84. PubMed ID: 22665137
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-Like Peptide-1 Cleavage Product Improves Cognitive Function in a Mouse Model of Down Syndrome.
Day SM; Yang W; Wang X; Stern JE; Zhou X; Macauley SL; Ma T
eNeuro; 2019; 6(2):. PubMed ID: 31040160
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide and Exercise Synergistically Attenuate Vascular Inflammation and Enhance Metabolic Insulin Action in Early Diet-Induced Obesity.
Liu J; Aylor KW; Liu Z
Diabetes; 2023 Jul; 72(7):918-931. PubMed ID: 37074396
[TBL] [Abstract][Full Text] [Related]
4. Long-Acting Neurotensin Synergizes With Liraglutide to Reverse Obesity Through a Melanocortin-Dependent Pathway.
Ratner C; He Z; Grunddal KV; Skov LJ; Hartmann B; Zhang F; Feuchtinger A; Bjerregaard A; Christoffersen C; Tschöp MH; Finan B; DiMarchi RD; Leinninger GM; Williams KW; Clemmensen C; Holst B
Diabetes; 2019 Jun; 68(6):1329-1340. PubMed ID: 30936142
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide modulates morpho-functional and inflammatory gastrointestinal responses in rats.
Gusmão-Nascimento JW; Nunes Cruz DM; Almeida Gama L; Luz Alves WD; Machado MPR; Corá LA; Américo MF
Eur J Clin Invest; 2024 Feb; 54(2):e14112. PubMed ID: 37846206
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide Reduces Alcohol Consumption, Anxiety, Memory Impairment, and Synapse Loss in Alcohol Dependent Mice.
Liu W; Wang Z; Wang W; Wang Z; Xing Y; Hölscher C
Neurochem Res; 2024 Apr; 49(4):1061-1075. PubMed ID: 38267691
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide ameliorates delirium-like behaviors of aged mice undergoing cardiac surgery by mitigating microglia activation via promoting mitophagy.
Jia M; Lv X; Zhu T; Shen JC; Liu WX; Yang JJ
Psychopharmacology (Berl); 2024 Apr; 241(4):687-698. PubMed ID: 37968531
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide and Insulin Have Contrary Effects on Adipogenesis of Human Adipose-Derived Stem Cells via Wnt Pathway.
Liu H; Zhan YL; Luo GJ; Zou LL; Li Y; Lu HY
Diabetes Metab Syndr Obes; 2020; 13():3075-3087. PubMed ID: 32943896
[TBL] [Abstract][Full Text] [Related]
9. The impact of dietary energy intake on cognitive aging.
Mattson MP
Front Aging Neurosci; 2010; 2():5. PubMed ID: 20552045
[TBL] [Abstract][Full Text] [Related]
10. D-ꞵ-hydroxybutyrate stabilizes hippocampal CA3-CA1 circuit during acute insulin resistance.
Kula B; Antal B; Weistuch C; Gackière F; Barre A; Velado V; Hubbard JM; Kukley M; Mujica-Parodi LR; Smith NA
PNAS Nexus; 2024 May; 3(5):pgae196. PubMed ID: 38818236
[TBL] [Abstract][Full Text] [Related]
11.
Kula B; Antal B; Weistuch C; Gackière F; Barre A; Velado V; Hubbard JM; Kukley M; Mujica-Parodi LR; Smith NA
bioRxiv; 2024 May; ():. PubMed ID: 37662316
[TBL] [Abstract][Full Text] [Related]
12. Erratum. Liraglutide and Exercise Synergistically Attenuate Vascular Inflammation and Enhance Metabolic Insulin Action in Early Diet-Induced Obesity. Diabetes 2023;72:918-931.
Liu J; Aylor KW; Liu Z
Diabetes; 2024 Jul; 73(7):1196. PubMed ID: 38652481
[No Abstract] [Full Text] [Related]
13. Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression.
Kariharan T; Nanayakkara G; Parameshwaran K; Bagasrawala I; Ahuja M; Abdel-Rahman E; Amin AT; Dhanasekaran M; Suppiramaniam V; Amin RH
Neurobiol Aging; 2015 Mar; 36(3):1451-61. PubMed ID: 25510319
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice.
Lennox R; Porter DW; Flatt PR; Holscher C; Irwin N; Gault VA
Neuropharmacology; 2014 Nov; 86():22-30. PubMed ID: 24998752
[TBL] [Abstract][Full Text] [Related]
15. Bariatric Surgery and Gut-Brain-Axis Driven Alterations in Cognition and Inflammation.
Custers E; Franco A; Kiliaan AJ
J Inflamm Res; 2023; 16():5495-5514. PubMed ID: 38026245
[TBL] [Abstract][Full Text] [Related]
16. Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development.
Singh DD; Shati AA; Alfaifi MY; Elbehairi SEI; Han I; Choi EH; Yadav DK
Cells; 2022 Nov; 11(23):. PubMed ID: 36497027
[TBL] [Abstract][Full Text] [Related]
17. The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases.
Cheng D; Yang S; Zhao X; Wang G
Drug Des Devel Ther; 2022; 16():665-684. PubMed ID: 35340338
[TBL] [Abstract][Full Text] [Related]
18. Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders.
Shah S; Dooms MM; Amaral-Garcia S; Igoillo-Esteve M
Front Pharmacol; 2021; 12():768023. PubMed ID: 34992533
[TBL] [Abstract][Full Text] [Related]
19. Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon-like peptide-1 receptor agonists.
Yassine HN; Solomon V; Thakral A; Sheikh-Bahaei N; Chui HC; Braskie MN; Schneider LS; Talbot K
Alzheimers Dement; 2022 Mar; 18(3):478-497. PubMed ID: 34647685
[TBL] [Abstract][Full Text] [Related]
20. Proglucagon-Derived Peptides as Therapeutics.
Lafferty RA; O'Harte FPM; Irwin N; Gault VA; Flatt PR
Front Endocrinol (Lausanne); 2021; 12():689678. PubMed ID: 34093449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
